Format

Send to

Choose Destination
PLoS One. 2011 Feb 7;6(2):e14665. doi: 10.1371/journal.pone.0014665.

Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism.

Author information

1
Department of Pathology and Immunology, Centre Médical Universitaire, University of Geneva, Geneva, Switzerland.

Erratum in

  • PLoS One. 2011;6(2).doi: 10.1371/annotation/a392bbef-b0ec-4c70-b403-74a7bad85178. Imhof, Beat [corrected to Imhof, Beat A].

Abstract

Reactive oxygen species, ROS, are regulators of endothelial cell migration, proliferation and survival, events critically involved in angiogenesis. Different isoforms of ROS-generating NOX enzymes are expressed in the vasculature and provide distinct signaling cues through differential localization and activation. We show that mice deficient in NOX1, but not NOX2 or NOX4, have impaired angiogenesis. NOX1 expression and activity is increased in primary mouse and human endothelial cells upon angiogenic stimulation. NOX1 silencing decreases endothelial cell migration and tube-like structure formation, through the inhibition of PPARα, a regulator of NF-κB. Administration of a novel NOX-specific inhibitor reduced angiogenesis and tumor growth in vivo in a PPARα dependent manner. In conclusion, vascular NOX1 is a critical mediator of angiogenesis and an attractive target for anti-angiogenic therapies.

PMID:
21326871
PMCID:
PMC3034713
DOI:
10.1371/journal.pone.0014665
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center